Abstract
The discovery of CRIPSR/Cas9 has led to great advances in the development of gene therapy due to its substantial efficiency in DNA editing over several cell models, showing, simultaneously, experimental simplicity and low costs. However, there are still barriers to be dealt with in order to fully explore its potential, like a delivery system to target specifically and biologically safe. W…